Table 2

Percentage of patients in each group receiving specified classes of drugs throughout follow-up

Patient category
Ab−T−Ab+T−Ab−T+Ab+T+Unknown*
n = 6n = 2n = 7n = 5n = 3
Diabetes medications
 Sulfonylureas8350578067
 Biguanides831008680100
 Meglitinides170000
 α-Glucosidase inhibitors33014033
Cholesterol medications
 Statins33100296067
 Fibrates00144033
 Niacin0500033
Blood pressure medication
 ACE inhibitors50100142067
 Angiotensin receptor blocker001400
 β-Blockers50502920100
 Calcium channel blockers00430100
 Diuretics33043067
 α-Blockers17043600
Other medications
 Levothyroxine sodium330000
 Aspirin1750144067
 Antiepileptic agent17014400
 Serotonin reuptake inhibitor0029033
 β2-Adrenergic agonist0014200
  • *Autoimmune positive 1 time point only.

  • †No patients were treated with thiazolidinediones, dipeptidyl peptidase-4 inhibitors, or sodium-glucose linked transporter 2 inhibitors.